Orphan drugs are medications developed to treat rare diseases, often defined as conditions affecting fewer than 200,000 people in the United States. Due to the small patient population, developing these drugs can be less financially viable, leading to special incentives and regulatory support for their development. Orphan drugs are also a therapeutic area in clinical research, focusing on finding treatments for rare and often overlooked conditions.